Wednesday, January 3, 2024

January 03, 2024 at 04:07PM CASGEVY

CASGEVY indicated for the treatment of sickle cell disease (SCD) in patients 12 years and older with recurrent vaso occlusive crises (VOCs).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/XdJDS3v
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)